• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchVaccinex
    Picture of Vaccinex logo

    VCNX — Vaccinex News Story

    $0.820.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $2.20m
    • Enterprise Value
      $2.78m
    • Revenue
      $0.60m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VCNX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VCNX Dividends
    All News

    NASDAQ RESUMED AT 08:01 AM

    Picture of Vaccinex logoVaccinex
    22/09/2020 13:01
    NASDAQ RESUMED  VCNX.O  AT 08:01 AM
    

    Recent news on Vaccinex

    See all news
    • Brief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update

      18/11/2024 13:49
    • Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard

      09/10/2024 21:41
    • Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds

      18/09/2024 14:23
    • Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease

      14/08/2024 13:47
    • Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease

      06/06/2024 13:41

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.